JP2019526628A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019526628A5 JP2019526628A5 JP2019531594A JP2019531594A JP2019526628A5 JP 2019526628 A5 JP2019526628 A5 JP 2019526628A5 JP 2019531594 A JP2019531594 A JP 2019531594A JP 2019531594 A JP2019531594 A JP 2019531594A JP 2019526628 A5 JP2019526628 A5 JP 2019526628A5
- Authority
- JP
- Japan
- Prior art keywords
- msoh
- compound
- suitable solvent
- crystal form
- isolating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 40
- 239000002904 solvent Substances 0.000 claims 17
- 239000013078 crystal Substances 0.000 claims 16
- 239000000725 suspension Substances 0.000 claims 9
- 238000001035 drying Methods 0.000 claims 7
- 238000004519 manufacturing process Methods 0.000 claims 7
- 238000000034 method Methods 0.000 claims 7
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 claims 4
- 206010016654 Fibrosis Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 230000004761 fibrosis Effects 0.000 claims 3
- 230000003176 fibrotic effect Effects 0.000 claims 3
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 claims 3
- 238000000634 powder X-ray diffraction Methods 0.000 claims 3
- 208000019425 cirrhosis of liver Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000001704 evaporation Methods 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000012296 anti-solvent Substances 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 238000000227 grinding Methods 0.000 claims 1
- 238000003801 milling Methods 0.000 claims 1
- 201000002793 renal fibrosis Diseases 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022113230A JP2022137223A (ja) | 2016-08-31 | 2022-07-14 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662382153P | 2016-08-31 | 2016-08-31 | |
| US62/382,153 | 2016-08-31 | ||
| PCT/US2017/049400 WO2018045043A1 (en) | 2016-08-31 | 2017-08-30 | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022113230A Division JP2022137223A (ja) | 2016-08-31 | 2022-07-14 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019526628A JP2019526628A (ja) | 2019-09-19 |
| JP2019526628A5 true JP2019526628A5 (https=) | 2020-10-08 |
Family
ID=61241572
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531594A Pending JP2019526628A (ja) | 2016-08-31 | 2017-08-30 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
| JP2022113230A Pending JP2022137223A (ja) | 2016-08-31 | 2022-07-14 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022113230A Pending JP2022137223A (ja) | 2016-08-31 | 2022-07-14 | セニクリビロクメシレートの固体形態及びセニクリビロクメシレートの固体形態を製造するプロセス |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10301287B2 (https=) |
| EP (1) | EP3506896A4 (https=) |
| JP (2) | JP2019526628A (https=) |
| KR (1) | KR20190057066A (https=) |
| CN (1) | CN110167550A (https=) |
| AU (1) | AU2017321594A1 (https=) |
| BR (1) | BR112019003987A2 (https=) |
| CA (1) | CA3034606A1 (https=) |
| MX (1) | MX2019002057A (https=) |
| RU (1) | RU2019109019A (https=) |
| SG (1) | SG11201901438VA (https=) |
| TW (1) | TW201823235A (https=) |
| WO (1) | WO2018045043A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019238041A1 (zh) * | 2018-06-12 | 2019-12-19 | 南京明德新药研发有限公司 | 一种丙烯酰胺类化合物的晶型及其制备方法 |
| US11613670B2 (en) * | 2018-06-18 | 2023-03-28 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| WO2019245517A1 (en) * | 2018-06-18 | 2019-12-26 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| US11591486B2 (en) | 2018-06-19 | 2023-02-28 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| US11426931B2 (en) | 2018-06-19 | 2022-08-30 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| WO2019245534A1 (en) * | 2018-06-19 | 2019-12-26 | Hewlett-Packard Development Company, L.P. | Three-dimensional printing |
| EP3844209B1 (en) * | 2018-08-31 | 2022-06-22 | Evonik Operations GmbH | Process for preparing a polymer powder |
| WO2021133811A1 (en) * | 2019-12-26 | 2021-07-01 | Teva Pharmaceuticals International Gmbh | Solid state forms of cenicriviroc and process for preparation thereof |
| EP4159730A4 (en) | 2020-05-22 | 2024-05-01 | Medshine Discovery Inc. | PYRIDINE DERIVATIVE AND APPLICATION THEREOF |
| JP7374372B2 (ja) * | 2021-02-22 | 2023-11-06 | 旭化成株式会社 | セルロースナノファイバーを含む組成物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62265270A (ja) | 1986-05-13 | 1987-11-18 | Zeria Shinyaku Kogyo Kk | 新規イミダゾ−ル誘導体およびそれらを有効成分とする抗潰瘍剤 |
| DE69520360T2 (de) | 1994-07-04 | 2001-08-09 | Takeda Chemical Industries, Ltd. | Phosphonsäure verbindungen imre herstellung und verwendung |
| EP1039899A2 (en) | 1997-12-19 | 2000-10-04 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative |
| AU5301599A (en) | 1998-08-20 | 2000-03-14 | Takeda Chemical Industries Ltd. | Quaternary ammonium salts and their use |
| WO2001017947A1 (en) | 1999-09-06 | 2001-03-15 | Takeda Chemical Industries, Ltd. | Process for the preparation of 2,3-dihydroazepine compounds |
| EP2206702B1 (en) | 2001-08-08 | 2011-12-28 | Tobira Therapeutics, Inc. | Bicyclic compound, production and use thereof |
| CN1649847A (zh) * | 2002-03-12 | 2005-08-03 | 武田药品工业株式会社 | 制备旋光亚砜衍生物的方法 |
| WO2005089714A1 (ja) | 2004-03-24 | 2005-09-29 | Takeda Pharmaceutical Company Limited | エマルション安定化製剤 |
| JP2007269628A (ja) * | 2004-05-28 | 2007-10-18 | Takeda Chem Ind Ltd | 医薬化合物の結晶 |
| GT200600148A (es) | 2005-04-14 | 2006-11-22 | Metodos para el tratamiento y la prevencion de fibrosis | |
| SG10201510402WA (en) | 2010-11-18 | 2016-01-28 | Univ Yale | Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| EP2846788A1 (en) | 2012-05-11 | 2015-03-18 | Akron Molecules AG | Use of compounds for the treatment of pain |
| SG10201708595YA (en) | 2013-05-15 | 2017-11-29 | Tobira Therapeutics Inc | Cenicriviroc compositions and methods of making and using the same |
| EP3119401A4 (en) * | 2014-03-21 | 2017-12-13 | Tobira Therapeutics, Inc. | Cenicriviroc for the treatment of fibrosis |
| MA39991A (fr) | 2014-06-02 | 2015-12-10 | Tobira Therapeutics Inc | Cénicriviroc pour le traitement de l'infection à vih-2 |
| BR112017013130A2 (pt) | 2014-12-23 | 2017-12-26 | Tobira Therapeutics Inc | processo de fabricação de cenicriviroc e análogos relacionados |
-
2017
- 2017-08-30 JP JP2019531594A patent/JP2019526628A/ja active Pending
- 2017-08-30 TW TW106129555A patent/TW201823235A/zh unknown
- 2017-08-30 RU RU2019109019A patent/RU2019109019A/ru not_active Application Discontinuation
- 2017-08-30 WO PCT/US2017/049400 patent/WO2018045043A1/en not_active Ceased
- 2017-08-30 CA CA3034606A patent/CA3034606A1/en not_active Abandoned
- 2017-08-30 AU AU2017321594A patent/AU2017321594A1/en not_active Abandoned
- 2017-08-30 CN CN201780061529.6A patent/CN110167550A/zh active Pending
- 2017-08-30 EP EP17847477.1A patent/EP3506896A4/en not_active Withdrawn
- 2017-08-30 SG SG11201901438VA patent/SG11201901438VA/en unknown
- 2017-08-30 KR KR1020197008786A patent/KR20190057066A/ko not_active Withdrawn
- 2017-08-30 MX MX2019002057A patent/MX2019002057A/es unknown
- 2017-08-30 BR BR112019003987A patent/BR112019003987A2/pt not_active Application Discontinuation
- 2017-08-30 US US15/691,191 patent/US10301287B2/en active Active
-
2022
- 2022-07-14 JP JP2022113230A patent/JP2022137223A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019526628A5 (https=) | ||
| JP2022068321A5 (https=) | ||
| JP6025755B2 (ja) | 多粒子ｌ−メントール製剤及びその関連する方法 | |
| JP2019509268A5 (https=) | ||
| JP2019505533A5 (https=) | ||
| RU2019109019A (ru) | Твердые формы ценикривирок мезилата и способы изготовления твердых форм ценикривирок мезилата | |
| JPWO1999034832A1 (ja) | 結晶学的に安定な非晶質セファロスポリンの組成物とその製造方法 | |
| JP2019505532A5 (https=) | ||
| JP2018513863A5 (https=) | ||
| JP2019516749A5 (https=) | ||
| JP2010515682A5 (https=) | ||
| JP2024095561A5 (https=) | ||
| JP2016539136A5 (https=) | ||
| JP2017515821A5 (https=) | ||
| WO2016107289A1 (zh) | 制备索非布韦晶型6的方法 | |
| WO2010129636A2 (en) | Lenalidomide polymorph | |
| CN104098570A (zh) | 替卡格雷晶型及其制备方法和用途 | |
| CN109311893A (zh) | 含有取代环戊基的吡咯并嘧啶化合物 | |
| JP2018516946A5 (https=) | ||
| JP2007519747A5 (https=) | ||
| WO2019107412A1 (ja) | 固体分散体 | |
| CN107427495A (zh) | 包含雷迪帕韦和索非布韦的药物组合物 | |
| CN1303065C (zh) | 氨溴索半胱氨酸类似物盐及其制备方法和用途 | |
| WO2017208169A1 (en) | Polymorphs of betrixaban & its maleate salt | |
| JP6621761B2 (ja) | 薬学的に活性な化合物の固体形態 |